Pythian and GigaOm Announce AI Partnership
Pythian, a leading data and AI services provider, partners with GigaOm to accelerate Enterprise AI adoption
OTTAWA, Ontario, April 02, 2025 (GLOBE NEWSWIRE) -- Pythian Services Inc. ('Pythian'), a leading global services company specializing in data, analytics, and AI solutions, announced a strategic partnership with GigaOm, a leading analyst firm, to empower businesses to achieve rapid AI readiness, executive alignment and ethical GenAI integration. The partnership highlights GigaOm's launch of its comprehensive Enterprise GenAI Maturity Model with Pythian as its primary partner.
'Pythian's proven expertise in data and AI makes them the ideal partner for the launch of our AI Maturity Framework,' said Howard Holton, chief operating officer at GigaOm. 'Together we're equipping businesses with the resources they need to accelerate their AI journey and achieve tangible results.'
The partnership addresses a critical need for businesses to understand and implement GenAI effectively and ethically. GigaOm's Enterprise GenAI Maturity Model provides a comprehensive, step-by-step roadmap for successfully integrating generative AI technologies into business operations.
The robust framework details six maturity levels—from Default (Level 0) to Leading (Level 5)—across key dimensions, including Core Technology, Data Quality, Ethical AI, Budgeting, AI Governance, Model Training, Data Security, Organizational Change Control and Operational Efficiency. Pythian's AI Workshop complements this model by offering hands-on educational sessions that demystify AI and foster internal alignment, significantly reducing the time required for decision-making from months to weeks.
'We are thrilled to partner with GigaOm to help businesses navigate the complexities of AI adoption,' stated Paul Lewis, chief technology officer at Pythian. 'The collaboration between GigaOm and Pythian offers our customers a streamlined two-step approach to AI strategy with our AI Workshop as the foundation.'
The AI Workshop is designed to provide businesses with the knowledge and alignment needed to confidently move forward with their AI initiatives. Following from Pythian's workshop, GigaOm's AI Maturity Framework provides powerful capabilities and tools to measure progress as customers confidently advance their overall AI strategy.
Pythian's expertise in data and AI, combined with GigaOm's insightful analysis and framework, creates a powerful synergy. Pythian's deep understanding of the practical application of AI technologies across various industries ensures businesses not only understand the value of AI, but also have a clear strategy for implementation. The AI Workshops are delivered by Pythian's team of Field CTOs and focus on real-world scenarios, making complex concepts accessible to all stakeholders.
'Through Pythian's valued partnership with GigaOm, we are providing customers with a seamless process toward AI enablement that will strengthen their ability to leverage game-changing technology for their respective businesses and allow them to enhance their competitive position within their market,' said Brooks Borcherding, CEO at Pythian.
Participants in Pythian's AI Workshop will gain a foundational understanding of AI technologies, learn how to identify relevant use cases, and develop a strategic roadmap using the AI Maturity Framework for implementation. The workshop facilitates crucial conversations among executives and technical teams leading to faster decision-making and a unified vision for AI adoption.
Schedule your AI Workshop today.
About GigaOm
GigaOm is an analyst firm led by real buyers and real engineers. By combining deep technical expertise with executive perspective, GigaOm delivers credible, actionable validation—because they built the systems, led the teams, and made the calls. Their reports, briefs, and enablement tools speak the language customers trust, backed by real-world testing to align marketing, sales, and the C-suite.
About Pythian
Founded in 1997, Pythian is a leading data and AI services provider specializing in digital transformation and operational excellence for enterprise customers. We help organizations optimize their data estates, helping them to drive AI enablement, innovation, and growth. Through strategic consulting, managed services and cloud migrations, we enable cost savings, risk reduction and seamless operations while preparing businesses to adopt AI and for the future of data management. A Google Cloud Premier Partner with multiple Specializations, including Data Analytics, Marketing Analytics, Machine Learning and a certified Google Cloud MSP, we've delivered thousands of professional and managed services projects for leading enterprises. For more information, visit www.pythian.com or follow us on X, LinkedIn, and our Blog.
Pythian Media Contacts
Matt MalangaSenior Vice President, Marketingmalanga@pythian.com+1 917-494-2867
Elisabeth GrantBranch Out Public Relationsegrant@branchoutpr.com+1 612-599-7797
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
KFSHRC Pioneering Clinical Trials and Gene Therapy Across the Region
KFSHRC accounts for 52.4% of all active clinical trials in Saudi Arabia. RIYADH, Saudi Arabia, June 04, 2025 (GLOBE NEWSWIRE) -- As part of Saudi Arabia's broader biotechnology transformation under Vision 2030, King Faisal Specialist Hospital & Research Centre (KFSHRC) solidified its role as the Kingdom's leading Clinical Trials hub in 2024 — conducting 52.4% of all active Clinical Trials nationwide, according to the Saudi National Institute of Health. This milestone reflects the sustained success of KFSHRC's Clinical Trials Transformation Initiative, launched in 2021 to build an integrated, patient-centered research ecosystem. By the end of 2024, the hospital had recorded 701 active research proposals, representing an 8% increase over the previous year. In Riyadh alone, research approvals rose by 20%, demonstrating growing alignment between scientific discovery and clinical care delivery. KFSHRC's research growth was matched by key innovation milestones. In 2024, it became the first in Saudi Arabia to locally produce CAR-T cells — a major step toward national self-sufficiency in advanced therapies. It also delivered a breakthrough in hemophilia care, using one-time gene therapy to restore clotting function in eight patients, eliminating preventive treatment and significantly improving quality of life. These advancements align closely with Saudi Arabia's Vision 2030 and National Biotechnology Strategy, which designate biotechnology as a national priority sector — aiming to localize therapeutic development, accelerate innovation, and establish global leadership by 2040. Complementing its scientific leadership, KFSHRC has also invested in public engagement, launching awareness campaigns in high-traffic public venues to promote Clinical Trials literacy and reduce misconceptions around participation. It is noteworthy that KFSHRC has been ranked first in the Middle East and Africa and 15th globally among the world's top 250 Academic Medical Centres for the third consecutive year, and recognised as the most valuable healthcare brand in the Kingdom and the Middle East, according to the 2025 Brand Finance rankings. Additionally, it was included in the World's Best Smart Hospitals list for 2025 by Newsweek magazine. For more information, visit or contact our media team at mediacoverage@ A photo accompanying this announcement is available at
Yahoo
an hour ago
- Yahoo
Apple stock hit with downgrade by Needham analysts, citing stiff AI competition
Apple (AAPL) stock was downgraded to Hold from Buy by Needham analysts who said the stock is overvalued amid growing AI competition. Analyst Laura Martin explained in a note to clients Wednesday that Apple is currently trading at a more expensive multiple than it has historically, just as the rise of generative AI threatens to disrupt the iPhone maker's businesses. Apple is currently the worst-performing stock of its "Magnificent Seven" Big Tech peers, down roughly 18% for the year. The company has faced lagging sales in China and a sluggish smartphone market. The stock was hit with two downgrades in January from Jefferies and Loop Capital. Shares, which stood just above $200 on Wednesday, are priced at roughly 26 times the company's projected 2026 earnings, a multiple 50% above its 10-year average and 25% above the current average forward-year 2026 price-to-earnings ratio for the S&P 500 (^GSPC), Martin noted. "We believe that, for this stock to work, it must have the catalyst of an iPhone replacement cycle, which we do not foresee in the next 12 months," Martin wrote. "Until then, we believe that $170-$180/share is a better entry level." She also said Apple could accelerate growth by deciding to "aggressively pursue an advertising revenue stream." Needham's downgrade comes as the smartphone market at large is experiencing a slump: Counterpoint Research on Wednesday lowered its 2025 annual growth forecast for global smartphone shipments to 1.9% from 4.2%, citing uncertainties related to US tariffs. Meanwhile, Apple is facing growing competition in AI. Martin wrote that "every Big Tech company is building platforms designed to displace AAPL's integrated hardware and software products in a GenAI [generative artificial intelligence] world." That includes Meta's AI smartglasses, as well as OpenAI and Jony Ive's development of a new mystery AI hardware device that could offer an AI alternative to smartphones, the analyst said. Apple also doesn't reap the benefits of AI Cloud revenue like its competitors. "While peers like Microsoft (MSFT), Google (GOOG), and Meta (META) are launching foundational models and GenAI-native platforms, AAPL still lacks a competitive LLM [large language model] or a developer ecosystem around GenAI capabilities," Martin wrote. In April, Apple stock's 200-day moving average rose above its 50-day moving average, a phenomenon called a "death cross." "This pattern is typically viewed as a bearish signal, indicating continued downward momentum," Martin wrote. The company faces other risk factors, such as the potential threat of losing $20 billion in annual revenue from Google as the Alphabet-owned (GOOGL, GOOG) tech giant awaits final orders from US Judge Amit Mehta in its landmark antitrust case. Apple is also staring down its own antitrust case. Apple is also getting pressured on the supply side: Trump is threatening a 25% tariff on its iPhones unless the company shifts production to the US, a process that could take more than five years. The company's culture may not help as it grapples with myriad challenges. Martin said in her note, "AAPL believes that it makes its own weather. This philosophy reflects a deep-seated cultural belief that AAPL operates on its own terms, largely independent of external trends, competitive pressures, or even macroeconomic conditions." The analyst said she worries that Apple's culture "[b]reeds complacency, which lowers urgency just as GenAI disruption threatens to re-tool the entire US economy," and "[m]akes AAPL slow to acknowledge negative shifts in the regulatory environment and rising geopolitical risks." Laura Bratton is a reporter for Yahoo Finance. Follow her on Bluesky @ Email her at Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
an hour ago
- Yahoo
Apple stock hit with downgrade by Needham analysts, citing stiff AI competition
Apple (AAPL) stock was downgraded to Hold from Buy by Needham analysts who said the stock is overvalued amid growing AI competition. Analyst Laura Martin explained in a note to clients Wednesday that Apple is currently trading at a more expensive multiple than it has historically, just as the rise of generative AI threatens to disrupt the iPhone maker's businesses. Apple is currently the worst-performing stock of its "Magnificent Seven" Big Tech peers, down roughly 18% for the year. The company has faced lagging sales in China and a sluggish smartphone market. The stock was hit with two downgrades in January from Jefferies and Loop Capital. Shares, which stood just above $200 on Wednesday, are priced at roughly 26 times the company's projected 2026 earnings, a multiple 50% above its 10-year average and 25% above the current average forward-year 2026 price-to-earnings ratio for the S&P 500 (^GSPC), Martin noted. "We believe that, for this stock to work, it must have the catalyst of an iPhone replacement cycle, which we do not foresee in the next 12 months," Martin wrote. "Until then, we believe that $170-$180/share is a better entry level." She also said Apple could accelerate growth by deciding to "aggressively pursue an advertising revenue stream." Needham's downgrade comes as the smartphone market at large is experiencing a slump: Counterpoint Research on Wednesday lowered its 2025 annual growth forecast for global smartphone shipments to 1.9% from 4.2%, citing uncertainties related to US tariffs. Meanwhile, Apple is facing growing competition in AI. Martin wrote that "every Big Tech company is building platforms designed to displace AAPL's integrated hardware and software products in a GenAI [generative artificial intelligence] world." That includes Meta's AI smartglasses, as well as OpenAI and Jony Ive's development of a new mystery AI hardware device that could offer an AI alternative to smartphones, the analyst said. Apple also doesn't reap the benefits of AI Cloud revenue like its competitors. "While peers like Microsoft (MSFT), Google (GOOG), and Meta (META) are launching foundational models and GenAI-native platforms, AAPL still lacks a competitive LLM [large language model] or a developer ecosystem around GenAI capabilities," Martin wrote. In April, Apple stock's 200-day moving average rose above its 50-day moving average, a phenomenon called a "death cross." "This pattern is typically viewed as a bearish signal, indicating continued downward momentum," Martin wrote. The company faces other risk factors, such as the potential threat of losing $20 billion in annual revenue from Google as the Alphabet-owned (GOOGL, GOOG) tech giant awaits final orders from US Judge Amit Mehta in its landmark antitrust case. Apple is also staring down its own antitrust case. Apple is also getting pressured on the supply side: Trump is threatening a 25% tariff on its iPhones unless the company shifts production to the US, a process that could take more than five years. The company's culture may not help as it grapples with myriad challenges. Martin said in her note, "AAPL believes that it makes its own weather. This philosophy reflects a deep-seated cultural belief that AAPL operates on its own terms, largely independent of external trends, competitive pressures, or even macroeconomic conditions." The analyst said she worries that Apple's culture "[b]reeds complacency, which lowers urgency just as GenAI disruption threatens to re-tool the entire US economy," and "[m]akes AAPL slow to acknowledge negative shifts in the regulatory environment and rising geopolitical risks." Laura Bratton is a reporter for Yahoo Finance. Follow her on Bluesky @ Email her at
